Philippe Genereux, MD, medical director of the Structural Heart Disease Program at Morristown Medical Center, discusses the use of transcatheter aortic valve replacement (TAVR) procedures in patients with severe, calcific aortic stenosis who are asymptomatic. 

This latest recall was initiated because electrical faults could cause the batteries to stop working, which leads to a risk of serious injury or death.

The USPSTF recommends statin use for high-risk patients between the ages of 40 to 75 to help prevent a first heart attack or stroke. Other patients in that same age group may also benefit, the group noted, but physician input is needed. 

The all-day summit, a collaboration between CRF and Fogarty Innovation, will focus on advances in healthcare technologies and patient care.

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

The news comes after the Onyx Frontier DES gained CE mark approval. It received FDA approval in May.

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

Ron Blankstein, MD, Brigham and Women's Hospital, explains recent advances in coronary computed tomography angiography (CCTA) technology. 

Compared to the individuals without a history of smoking, both current and former smokers had thicker, weaker and heavier hearts.

A new study out of Korea found that an increase in alcohol consumption is linked with a higher risk for all cancers, including alcohol-related cancers.